53 related articles for article (PubMed ID: 9208876)
1. Effect of alpha-interferons on immune function.
Herberman RB
Semin Oncol; 1997 Jun; 24(3 Suppl 9):S9-78-S9-80. PubMed ID: 9208876
[TBL] [Abstract][Full Text] [Related]
2. Biologic activities of natural and synthetic type I interferons.
Pfeffer LM
Semin Oncol; 1997 Jun; 24(3 Suppl 9):S9-63-S9-69. PubMed ID: 9208874
[TBL] [Abstract][Full Text] [Related]
3. Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons.
Pfeffer LM; Dinarello CA; Herberman RB; Williams BR; Borden EC; Bordens R; Walter MR; Nagabhushan TL; Trotta PP; Pestka S
Cancer Res; 1998 Jun; 58(12):2489-99. PubMed ID: 9635566
[TBL] [Abstract][Full Text] [Related]
4. Biological basis for a proper clinical application of alpha interferons.
Antonelli G
New Microbiol; 2008 Jul; 31(3):305-18. PubMed ID: 18843884
[TBL] [Abstract][Full Text] [Related]
5. Directed evolution of gene-shuffled IFN-alpha molecules with activity profiles tailored for treatment of chronic viral diseases.
Brideau-Andersen AD; Huang X; Sun SC; Chen TT; Stark D; Sas IJ; Zadik L; Dawes GN; Guptill DR; McCord R; Govindarajan S; Roy A; Yang S; Gao J; Chen YH; Skartved NJ; Pedersen AK; Lin D; Locher CP; Rebbapragada I; Jensen AD; Bass SH; Nissen TL; Viswanathan S; Foster GR; Symons JA; Patten PA
Proc Natl Acad Sci U S A; 2007 May; 104(20):8269-74. PubMed ID: 17494769
[TBL] [Abstract][Full Text] [Related]
6. Characterization of gene expression profile in rat Kupffer cells stimulated with IFN-alpha or IFN-gamma.
Zocco MA; Carloni E; Pescatori M; Saulnier N; Lupascu A; Nista EC; Novi M; Candelli M; Cimica V; Mihm S; Gasbarrini G; Ramadori G; Gasbarrini A
Dig Liver Dis; 2006 Aug; 38(8):563-77. PubMed ID: 16807150
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
[TBL] [Abstract][Full Text] [Related]
8. Functional significance of globotriaosyl ceramide in interferon-alpha(2)/type 1 interferon receptor-mediated antiviral activity.
Khine AA; Lingwood CA
J Cell Physiol; 2000 Jan; 182(1):97-108. PubMed ID: 10567921
[TBL] [Abstract][Full Text] [Related]
9. Codelivery of PEG-IFN-alpha inhibits HCV DNA vaccine-induced T cell responses but not humoral responses in African green monkeys.
Park SH; Lee SR; Hyun BH; Kim BM; Sung YC
Vaccine; 2008 Jul; 26(32):3978-83. PubMed ID: 18556097
[TBL] [Abstract][Full Text] [Related]
10. Antimetastatic effect of CpG DNA mediated by type I IFN.
Hafner M; Zawatzky R; Hirtreiter C; Buurman WA; Echtenacher B; Hehlgans T; Männel DN
Cancer Res; 2001 Jul; 61(14):5523-8. PubMed ID: 11454702
[TBL] [Abstract][Full Text] [Related]
11. The effectors of killer activity induced by interferon-alpha and gamma in peripheral blood mononuclear cells.
Sakaguchi M; Kubota S; Nishikido M; Taniguchi K; Inuzuka S; Saito Y; Kanetake H; Koga S
Int J Mol Med; 2002 Sep; 10(3):317-20. PubMed ID: 12165807
[TBL] [Abstract][Full Text] [Related]
12. Role of early cytokines, including alpha and beta interferons (IFN-alpha/beta), in innate and adaptive immune responses to viral infections.
Biron CA
Semin Immunol; 1998 Oct; 10(5):383-90. PubMed ID: 9799713
[TBL] [Abstract][Full Text] [Related]
13. Interferon-alpha and cancer: mechanisms of action and new perspectives of clinical use.
Ferrantini M; Capone I; Belardelli F
Biochimie; 2007; 89(6-7):884-93. PubMed ID: 17532550
[TBL] [Abstract][Full Text] [Related]
14. A new interferon, limitin, displays equivalent immunomodulatory and antitumor activities without myelosuppressive properties as compared with interferon-alpha.
Kawamoto S; Oritani K; Asakura E; Ishikawa J; Koyama M; Miyano K; Iwamoto M; Yasuda S; Nakakubo H; Hirayama F; Ishida N; Ujiie H; Masaie H; Tomiyama Y
Exp Hematol; 2004 Sep; 32(9):797-805. PubMed ID: 15345280
[TBL] [Abstract][Full Text] [Related]
15. The combination of IL-21 and IFN-alpha boosts STAT3 activation, cytotoxicity and experimental tumor therapy.
Eriksen KW; Søndergaard H; Woetmann A; Krejsgaard T; Skak K; Geisler C; Wasik MA; Odum N
Mol Immunol; 2009 Feb; 46(5):812-20. PubMed ID: 18947877
[TBL] [Abstract][Full Text] [Related]
16. Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line.
Zhu H; Zhao H; Collins CD; Eckenrode SE; Run Q; McIndoe RA; Crawford JM; Nelson DR; She JX; Liu C
Hepatology; 2003 May; 37(5):1180-8. PubMed ID: 12717400
[TBL] [Abstract][Full Text] [Related]
17. Induction of interferon-gamma from natural killer cells by immunostimulatory CpG DNA is mediated through plasmacytoid-dendritic-cell-produced interferon-alpha and tumour necrosis factor-alpha.
Marshall JD; Heeke DS; Abbate C; Yee P; Van Nest G
Immunology; 2006 Jan; 117(1):38-46. PubMed ID: 16423039
[TBL] [Abstract][Full Text] [Related]
18. Melanoma cells exhibit variable signal transducer and activator of transcription 1 phosphorylation and a reduced response to IFN-alpha compared with immune effector cells.
Lesinski GB; Trefry J; Brasdovich M; Kondadasula SV; Sackey K; Zimmerer JM; Chaudhury AR; Yu L; Zhang X; Crespin TR; Walker MJ; Carson WE
Clin Cancer Res; 2007 Sep; 13(17):5010-9. PubMed ID: 17785551
[TBL] [Abstract][Full Text] [Related]
19. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
[TBL] [Abstract][Full Text] [Related]
20. Adenosine and IFN-{alpha} synergistically increase IFN-gamma production of human NK cells.
Jeffe F; Stegmann KA; Broelsch F; Manns MP; Cornberg M; Wedemeyer H
J Leukoc Biol; 2009 Mar; 85(3):452-61. PubMed ID: 19095736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
